Revium Recovery Inc
Revium Rx. operates as a pre-clinical stage biopharmaceutical company focused on the development of nanoparticle-based therapies in the United States. The company develops lipid-based platforms for a variety of uses including antimicrobial resistance and solid tumors. The company specializes in infectious diseases, including antibiotic-resistant infections, solid tumors and vaccination. The compa… Read more
Revium Recovery Inc (RVRC) - Net Assets
Latest net assets as of June 2025: $18.59 Million USD
Based on the latest financial reports, Revium Recovery Inc (RVRC) has net assets worth $18.59 Million USD as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($19.24 Million) and total liabilities ($645.00K). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $18.59 Million |
| % of Total Assets | 96.65% |
| Annual Growth Rate | N/A |
| 5-Year Change | 1399.76% |
| 10-Year Change | N/A |
| Growth Volatility | 555.26 |
Revium Recovery Inc - Net Assets Trend (2018–2024)
This chart illustrates how Revium Recovery Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Revium Recovery Inc (2018–2024)
The table below shows the annual net assets of Revium Recovery Inc from 2018 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $18.79 Million | +242.54% |
| 2023-12-31 | $5.49 Million | +1306.67% |
| 2022-12-31 | $390.00K | -58.33% |
| 2021-12-31 | $936.00K | -25.30% |
| 2020-12-31 | $1.25 Million | +25603.77% |
| 2018-12-31 | $-4.91K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Revium Recovery Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 1044055000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $58.00K | 0.31% |
| Other Components | $30.22 Million | 160.81% |
| Total Equity | $18.79 Million | 100.00% |
Revium Recovery Inc Competitors by Market Cap
The table below lists competitors of Revium Recovery Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
BEYOND MED TEC. INC. NEW
F:7FM
|
$10.96 Million |
|
Nupur Recyclers Limited
NSE:NRL
|
$10.96 Million |
|
Banimmo S.A.
LSE:0NG8
|
$10.97 Million |
|
Metro Systems Corporation Public Company Limited
BK:MSC
|
$10.97 Million |
|
Shalimar Paints Limited
NSE:SHALPAINTS
|
$10.96 Million |
|
Pacific Orient Bhd
KLSE:6009
|
$10.96 Million |
|
The Practical Solution Public Company Limited
BK:TPS
|
$10.96 Million |
|
Nosa Med AB
ST:NOSA
|
$10.96 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Revium Recovery Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 5,486,000 to 18,792,000, a change of 13,306,000 (242.5%).
- Net loss of 3,478,000 reduced equity.
- Other factors increased equity by 16,784,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-3.48 Million | -18.51% |
| Other Changes | $16.78 Million | +89.31% |
| Total Change | $- | 242.54% |
Book Value vs Market Value Analysis
This analysis compares Revium Recovery Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.62x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2018-12-31 | $-0.06 | $0.50 | x |
| 2020-12-31 | $3.53 | $0.50 | x |
| 2021-12-31 | $0.08 | $0.50 | x |
| 2022-12-31 | $0.01 | $0.50 | x |
| 2023-12-31 | $0.19 | $0.50 | x |
| 2024-12-31 | $0.31 | $0.50 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Revium Recovery Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -18.51%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 1.02x
- Recent ROE (-18.51%) is above the historical average (-96.47%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2018 | 0.00% | 0.00% | 0.00x | 0.00x | $-4.42K |
| 2020 | -44.53% | 0.00% | 0.00x | 1.28x | $-683.30K |
| 2021 | -192.31% | 0.00% | 0.00x | 1.07x | $-1.89 Million |
| 2022 | -311.03% | 0.00% | 0.00x | 1.18x | $-1.25 Million |
| 2023 | -12.45% | 0.00% | 0.00x | 1.03x | $-1.23 Million |
| 2024 | -18.51% | 0.00% | 0.00x | 1.02x | $-5.36 Million |
Industry Comparison
This section compares Revium Recovery Inc's net assets metrics with peer companies in the Health Information Services industry.
Industry Context
- Industry: Health Information Services
- Average net assets among peers: $79,108,599
- Average return on equity (ROE) among peers: -247.59%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Revium Recovery Inc (RVRC) | $18.59 Million | 0.00% | 0.03x | $10.96 Million |
| Accolade, Inc. (ACCD) | $473.79 Million | -97.02% | 0.91x | $448.32 Million |
| Achiko AG (ACHKF) | $-4.58 Million | 0.00% | 0.00x | $314.42K |
| Ascom Holding AG (ACMLF) | $78.70 Million | 22.11% | 1.51x | $152.13 Million |
| Accelera Innovations Inc (ACNV) | $-462.52K | 0.00% | 0.00x | $5.72K |
| Aclarion Inc (ACON) | $-7.08 Million | 0.00% | 0.00x | $1.89 Million |
| Alternate Health Corp (AHGIF) | $1.07 Million | -2231.82% | 7.94x | $6.50K |
| AI/ML Innovations Inc (AIMLF) | $2.09 Million | -130.52% | 0.72x | $6.84 Million |
| NetraMark Holdings Inc. (AINMF) | $-198.56K | 0.00% | 0.00x | $70.13 Million |
| AMJ Global Technology (AMJT) | $-21.78K | 0.00% | 0.00x | $10.99 Million |
| American Well Corp (AMWL) | $247.79 Million | -38.62% | 0.31x | $78.62 Million |